Background: The sensitivity to detect small changes in body composition (fat mass and fat-free mass) largely depends on the precision of the instrument. We compared EchoMRI-AH and dual-energy X-ray absorptiometry (DXA) (Hologic QDR-4500A) for estimating fat mass in 301 volunteers. Methods: Body composition was evaluated in 136 males and 165 females with a large range of body mass index (BMI) (19À49 kg m À2 ) and age (19À91 years old) using DXA and EchoMRI-AH. In a subsample of 13 lean (BMI ¼ 19-25 kg m À2 ) and 21 overweight/obese (BMI425 kg m À2 ) individuals, within-subject precision was evaluated from repeated measurements taken within 1 h (n ¼ 3) and 1 week apart (mean of three measurements taken on each day). Results: Using Bland-Altman analysis, we compared the mean of the fat mass measurements versus the difference in fat mass measured by both instruments. We found that EchoMRI-AH quantified larger amount of fat versus DXA in non-obese (BMIo30 kg m À2 (1.1 kg, 95% confidence interval (CI 95 ):À3.7 to 6.0)) and obese (BMIX30 kg m À2 (4.2 kg, CI 95 :À1.4 to 9.8)) participants. Within-subject precision (coefficient of variation, %) in fat mass measured within 1 h was remarkably better when measured by EchoMRI-AH than DXA (o0.5 versus o1.5%, respectively; Po0.001). However, 1-week apart within-subject variability showed similar values for both instruments (o2.2%; P ¼ 0.15). Conclusions: EchoMRI-AH yielded greater fat mass values when compared with DXA (Hologic QDR-4500A), particularly in fatter subjects. EchoMRI-AH and DXA showed similar 1-week apart precision when fat mass was measured both in lean and overweight/obese individuals.
Introduction
Excess body fat is associated with many health impairments and contributes to excess morbidity and mortality. 1 Behavioral and pharmacological treatments are available to reduce excess fat mass and, therefore, improve health. 2, 3 Assessment of the efficacy of these interventions requires instruments capable of measuring small changes in fat mass. Recently, a quantitative nuclear magnetic resonance instrument to measure whole-body composition was introduced (EchoMRI-AH). EchoMRI-AH is a non-imaging method that uses a low-strength magnetic field to count hydrogen atoms and, therefore, measure water and fat mass with remarkable precision in small animals. 4 By detecting differences in the spin characteristics between hydrogen atoms in lipid and water, EchoMRI-AH quantifies the mass of fat, water and lean tissue within a subject. Importantly, EchoMRI-AH does not rely on ionizing radiation as does dual-energy X-ray absorptiometry (DXA). Furthermore, while the precision and accuracy of DXA can be significantly compromised by subject movements, the EchoMRI-AH technology is not affected by these variables. Fat mass can be accurately measured by a four-compartment model, which is considered the gold standard for estimating fat mass in humans. This model includes measurements of body density, total body water, total bone mineral mass and body weight. In humans, EchoMRI-AH underestimated the amount of fat mass when compared with a four-compartment model. 5 This difference was accentuated as the amount of fat mass increased. 5 A similar result was observed when EchoMRI-AH was compared against DXA. 5 As a small number of subjects was included in that study (n ¼ 30), we compared whole-body composition measured by DXA and EchoMRI-AH in a larger sample (n ¼ 301). Additionally, we determined the withinsubject body composition precision from repeated measurements taken within 1 h and 1 week apart.
Subjects and methods

Subjects
In all, 301 participants (136 males and 165 females) covering a large range of age and body mass were recruited by advertising (Table 1) . Distribution by sex, age and body mass index (BMI) is shown in Table 2 . Participants had body weight changes o2 kg for at least 3 months before enrollment in the study. Pregnant/lactating females or attempting to become pregnant were excluded from the study. Volunteers enrolled in pharmacological and/or lifestyle clinical trials for obesity or diabetes were excluded. Additionally, we excluded individuals with ferromagnetic materials, pacemakers or defibrillators or weighing more than 150 kg. A subsample of 34 participants was recruited to assess the within-subject body composition variability using EchoMRI-AH and DXA. The protocol was approved by the Pennington Biomedical Research Center Institutional Review Board and all subjects provided written informed consent before study participation.
Experimental design
Participants were instructed to avoid intense physical activity for the 2 days preceding body composition testing. After an overnight fast, body weight was measured while subjects wore a gown after emptying their bladder. Then, body composition was measured using DXA and EchoMRI-AH in a random order. Both instruments are located in the same temperature-controlled room (24.6 ± 0.5 1C; s.d.) and both measurements were completed within 20 min.
In a subsample of 34 individuals (18 males and 16 females) and following the same protocol described above, three measurements of body composition using both instruments were performed alternately within 1 h on day 1. The exact sequence of measurements was repeated 1 week later (day 8). Participants were instructed to maintain their usual food intake and physical activity pattern in between those sets of measurements.
Assessment of human body composition by EchoMRI-AH instrument
The EchoMRI-AH (with proprietary software) is 3.66 m long, 1.45 m wide and 1.52 m high. The subject is introduced on a rolling sled-mounted bed into an internal 0.74 m square bore extending the length of the instrument. The bore is surrounded by a resistive electromagnet, which generates a static low-intensity field of 0.0065 T. Hydrogen nuclei are stimulated by radio frequency pulses in the magnetic field. Their subsequent relaxation generates electromagnetic signals characteristic of the chemical environment in which the protons are incorporated. These are detected by an aerial antenna surrounding the bore and processed to derive total fat, lean and free water masses. 4 Calibration with known standards allows the expression of the numbers in kilograms. At the start of each day, the instrument was calibrated according to manufacturers' instructions using 45 kg Canola rapeseed oil at room temperature. Each EchoMRI-AH measurement lasted o5 min. The instrument generates values for whole-body fat and lean (bone mass not included) masses.
Assessment of human body composition by DXA instrument Whole-body composition was measured on a Hologic DXA in the fan beam mode (QDR-4500A; Hologic, Waltham, MA, USA) using the software provided by the manufacturer (QDR for Windows Version 11.1.2). The instrument generates values for whole-body fat mass, fat-free mass and bone mass. The difference between whole-body fat-free mass and bone mass was calculated and this value was compared against lean mass estimated by EchoMRI-AH.
Statistical analysis
All analyses were performed using SAS version 9.1.3 (SAS Institute, Cary, NC, USA). Within each sex, Pearson and Bland-Altman analyses were used to compare fat and lean mass measurements obtained by EchoMRI-AH and DXA. 6 Regression analysis was used to calculate the slope and intercept values between the differences in fat/lean mass estimated by both instruments versus the mean in fat/lean Human body composition assessment JE Galgani et al mass. Analysis of covariance was performed to assess fat mass and lean mass differences between instruments (DXA and EchoMRI-AH), time (days 1 and 8) and their interaction. Within-subject variability was estimated on a single day and 1 week apart as the coefficient of variation (%) using one-way ANOVA to calculate the between-subject variance (S 2 b ) and within-subject variance (S 2 w ). Single-day within-subject variability was calculated from the three repeated measurements of fat and lean masses. Within-subject variability was also estimated 1 week apart using the average of the three repeated measurements taken on each week. F-tests were used to compare variances between instruments. The 95% confidence intervals (CI 95 ) were calculated as s.d. times 1.96. Po0.05 was considered statistically significant.
Results
Agreement in body composition between EchoMRI-AH and DXA Fat mass measured by EchoMRI-AH and DXA were highly correlated both in males and females ( Figure 1 ). The agreement in fat mass between instruments is shown in the Bland-Altman plots in Figure 2 . Males and females showed a similar pattern characterized by a direct relationship between the difference in fat mass measured by both instruments and the mean of the measurements (males: r ¼ 0.74; Po0.0001; females: r ¼ 0.75; Po0.0001). In most of the individuals, and particularly those with larger fat mass, EchoMRI-AH determined a greater amount of fat compared with DXA with a mean difference for non-obese (o30 kg m
À2
) and obese (BMIX30 kg m À2 ) individuals of 1.1 kg (CI 95 :À3.7 to 6.0) and 4.2 kg (CI 95 :À1.4 to 9.8), respectively ( Figure 2) . In relative terms, the mean difference corresponded to 3.6% (CI 95 :À27 to 34) and 10.5% (CI 95 :À5 to 26) in non-obese and obese subjects, respectively. The slopes calculated in males and females were 0.21±0.02 kg per kg fat mass (Po0.0001) and 0.15 ± 0.01 kg per kg fat mass (Po0.0001), respectively. Consistently, the difference in fat mass measured by both methods against BMI showed a positive slope in males (0.32 ± 0.04 kg per unit BMI; Human body composition assessment JE Galgani et al Po0.0001) and females (0.26±0.02 kg per unit BMI; Po0.0001). Lean mass measured by EchoMRI-AH and DXA were highly correlated both in males and females (Figure 3 ). Lean mass estimated by both instruments showed a better agreement in males with a slope not different from zero (À0.048±0.034 kg per kg lean mass; P ¼ 0.16), an intercept of À4.71±2.14 kg (P ¼ 0.03) and a mean difference between instruments of À7.7 kg (CI 95 :À15 to À1) equivalent to À11.7% (CI 95 :À22 to À2) (Figure 2 ). Females showed an inverse relationship between the difference in lean mass measured by both instruments and the mean of the measurements (r ¼ À0.44; Po0.0001; slope ¼ À0.20±0.03 kg per kg lean mass; Po0.0001) with a mean difference between instruments of À7.5 kg (CI 95 :À14 to À2), equivalent to À15.2% (CI 95 :À26 to À5) (Figure 2) . The relationship between the differences in lean mass measured by both methods with BMI showed negative slopes in males (À0.38 ± 0.04 kg per unit BMI; Po0.0001) and females (À0.32±0.03 kg per unit BMI; Po0.0001; data not shown).
Comparison of the precision
The characteristics of the subset of subjects participating in the precision study are shown in ) individuals. The withinsubject body weight s.d. and CV% were 0.53 kg and 0.8%, and 0.69 kg and 0.7% in lean and overweight/obese subjects, respectively. Fat mass showed similar values between instruments (P ¼ 0.65) and days (P ¼ 0.97; Table 4 ). Lean mass showed similar values between days (P ¼ 0.99); however, DXA measured a greater amount of lean mass when compared with EchoMRI-AH (P ¼ 0.03; Table 4 ).
Within-subject variability in fat mass calculated from three repeated measurements taken within 1 h was virtually identical on days 1 and 8 using both DXA or EchoMRI-AH (P=0.99). Therefore, only data on day 1 are shown. Withinsubject s.d. in fat mass measured by EchoMRI-AH was o120 g in lean and overweight/obese individuals. This value Human body composition assessment JE Galgani et al was at least three times lower when compared with DXA (Po0.001; Table 4 ). In relative terms, fat mass showed a within-subject CV% o0.5% for EchoMRI-AH and 1.5% for DXA when calculated over 1 h (Figure 4 ). Within-subject variability in lean mass measured from three repeated measurements showed similar results when EchoMRI-AH and DXA were compared (P ¼ 0.18; Table 4 ). The withinsubject CV% in lean mass measured by both instruments was around 0.45 and 0.80% in lean and overweight/obese subjects, respectively. Within-subject variability was also calculated for fat and lean masses from mean values obtained on days 1 and 8 (Table 4 and Figure 4 ). When fat mass was estimated 1 week apart by EchoMRI-AH, within-subject variability was 4two-fold higher than within-subject variability calculated over 1 h both in lean and overweight/obese individuals (Po0.0001; Table 4 and Figure 4 ). However, DXA showed similar within-subject variability calculated over 1 h or 1 week in both groups (P ¼ 0.09; Table 4 and Figure 4 ). In summary, 1-week apart within-subject CV% for fat mass was o2.2% for both instruments (Figure 4) . One-week apart within-subject variability in lean mass showed a CV% o1.5% in lean and overweight/obese individuals for both instruments.
The change in body weight after 1 week (day 8Àday 1) was compared with the change in fat and lean masses over the same period measured by DXA and EchoMRI-AH. Mean change in fat mass for DXA was À0.13 kg (CI 95 :À1.2 to 0.9) and for EchoMRI-AH it was À0.06 kg (CI 95 :À0.88 to 0.75). The changes in body weight did not relate to the changes in fat mass measured by DXA (r ¼ À0.09; P ¼ 0.60), whereas a significant positive association was found using EchoMRI-AH (r ¼ 0.66; Po0.001; Figure 5 ). We also found similar s.d. values for the change in fat mass in lean (DXA: 0.47 kg and EchoMRI-AH: 0.36 kg; P ¼ 0.17) and overweight/obese (DXA: 0.54 kg and EchoMRI-AH: 0.45 kg; P ¼ 0.22) individuals.
In regard to the change in lean mass over 1 week, a direct association with the change in body weight was observed when DXA (r ¼ 0.87; Po0.001) and EchoMRI-AH (P ¼ 0.65; Po0.001) were used (data not shown).
Discussion
This study showed that EchoMRI-AH yielded higher fat mass values when compared with DXA (QDR 4500A). This observation is in contrast to a previous report showing that EchoMRI-AH yielded lesser amount of fat mass when compared with DXA (Lunar Prodigy) or a four-compartment model. 5 Methodological differences between studies might explain our divergent results. First, we did not include a four-compartment model that would allow better comparison of measurements. Second, the measurement of fat mass depends on the hardware (DXA machine) and software (algorithms) used, which is different between manufacturers. 7, 8 Finally, our study included a large sample size with large ranges of BMI and body fat. The underestimation of fat mass by DXA relative to EchoMRI-AH, particularly in obese individuals, may have a physical explanation. For the DXA methodology, photons passing through tissues are absorbed or scattered (that is, attenuation). The attenuation is a function of the length of the absorber (that is, human body tissues) and the linear attenuation coefficient of the substance (that is, tissue chemical composition). 9 Basically, X-ray penetration decreases as tissue thickness and depth increase leading to an underestimation of the amount of fat when compared with direct analysis. 10 In contrast, the measurement of fat mass by nuclear magnetic resonance should not be influenced by tissue thickness, depth or even the shape of the object to analyze. Therefore, EchoMRI-AH might provide a more accurate measure of fat mass in obese individuals when compared with DXA. Alternatively, QDR 4500A (DXA instrument) has repeatedly shown to underestimate fat mass when compared with criterion methods such as total body Human body composition assessment JE Galgani et al water, densitometry or a four-compartment model. Such underestimation is around 10% when compared with a four-compartment model. 11 EchoMRI-AH showed a remarkable better precision than DXA to estimate fat mass when evaluated from three repeated measurements performed within 1 h. As negligible changes in fat mass are expected to occur in such as short period of time, the observed errors become a surrogate for the analytical precision. In that case, an 'analytical error' o0.5% for EchoMRI-AH and 1.5% for DXA (Hologic QDR-4500A) were observed both in lean and overweight/ obese individuals. However, within-subject variability calculated over 1 week showed similar values for both instruments, being close to 2 and 1% in lean and overweight/obese subjects, respectively.
In the present study, 1-week apart precision (s.d.: 0.2-0.3 kg) in fat mass measured by EchoMRI-AH was close to calculated precision from repeated measurements taken over a day (two in the morning and two in the afternoon; s.d.: 0.2-0.4 kg) by Napolitano et al. 5 As
Napolitano et al. 5 made some of their measurements after a meal, they speculated that the thermic effect of food and increased core temperature might increase the signal from central fat and then the total amount of fat detected. In our study, changes in core temperature are presumably lower because our measurements were always performed after an overnight fast. As expected, body weight did not significantly change after 1 week. Within-subject variability was o1% and similar to previously reported results over a consecutive 12-day period. 12 We related the change in body weight over 1 week with the change in fat and lean mass over the same period of time. The fluctuation in body weight was related to the change in fat mass measured by EchoMRI-AH but not by DXA, whereas the change in lean mass measured by DXA or EchoMRI-AH were both associated with the change in body weight. Assuming that most of the change in body weight is accounted for by body water gain or loss, with minimal changes in body fat, changes in total mass and fat mass should not be related, whereas a positive association with the change in lean mass should be noted. Such prediction fits with our DXA-derived results. On the contrary, if a change in body weight was accompanied by a parallel change in fat mass, then, this is better picked if fat mass is measured by EchoMRI-AH. The lack of a reference method to measure body composition is impeding efforts to better measure the accuracy of DXA and EchoMRI-AH and, therefore, the ability to detect changes in body composition.
In conclusion, EchoMRI-AH yielded greater fat mass values when compared with DXA (Hologic QDR-4500A), particularly in fatter subjects. As DXA has physical limitations in its ability to measure body composition from obese subjects (not the case for nuclear magnetic resonance), EchoMRI-AH has probably a better reliability in determining fat mass in fatter individuals. Further assessments of accuracy, specificity and sensitivity of EchoMRI-AH will be needed to confirm such prediction. When precision was calculated from repeated measurements taken over a short period of time (minutes), EchoMRI-AH showed a remarkably better precision than DXA (o0.5 versus o1.5%, respectively). However, when precision was calculated over 1 week, similar values were found for both instruments (o2.2%).
